By Roshan Shrestha and Andrew Alul ( April 1, 2025, 6:38 PM EDT) -- The U.S. Court of Appeals for the Federal Circuit's March 14 decision in Regeneron Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. reaffirmed a critical principle in patent law: When a claim lists elements separately, the clear implication is that they are distinct elements.[1]...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.